• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . The Prevalence of Early- and Late-Onset Bacterial, Viral and Fungal Respiratory Superinfections in Invasively Ventilated COVID-19 Pati

tetano

Editor, Senior Moderator
J Med Virol


. 2021 Dec 24.
doi: 10.1002/jmv.27548. Online ahead of print.
The Prevalence of Early- and Late-Onset Bacterial, Viral and Fungal Respiratory Superinfections in Invasively Ventilated COVID-19 Patients


Maria Paparoupa[SUP] 1 [/SUP], Razaz Aldemyati[SUP] 1 2 [/SUP], Hannes Roggenkamp[SUP] 3 [/SUP], Benjamin Berinson[SUP] 3 [/SUP], Dominik Nörz[SUP] 3 [/SUP], Flaminia Olearo[SUP] 3 [/SUP], Stefan Kluge[SUP] 1 [/SUP], Kevin Roedl[SUP] 1 [/SUP], Geraldine de Heer[SUP] 1 [/SUP], Dominic Wichmann[SUP] 1 [/SUP]



Affiliations

Abstract

The role of respiratory superinfections in patients with COVID-19 pneumonia remains unclear. We investigated the prevalence of early- and late onset superinfections in invasively ventilated patients with COVID-19 pneumonia, admitted to our department of intensive care medicine between March 2020 and November 2020. Of the 102 cases, 74 (72.5%) received invasive ventilation and were tested for viral, bacterial and fungal pathogens on day 0-7, 8-14 and 15-21 after the initiation of mechanical ventilation. Approximately 45% developed one or more respiratory superinfections. There was a clear correlation between the duration of invasive ventilation and the prevalence of co-infecting pathogens. Males, patients with obesity and those suffering from chronic obstructive pulmonary disease and/or diabetes mellitus had a significantly higher probability to develop a respiratory superinfection. The prevalence of viral co-infections was high, with a predominance of herpes simplex virus (HSV), followed by cytomegalovirus (CMV). No respiratory viruses or intracellular bacteria were detected in our cohort. We observed a high co-incidence between Aspergillus fumigatus and HSV infection. Gram-negative bacteria were the most frequent pathogen group. Klebsiella aerogenes was detected early after intubation, while Klebsiella pneumoniae and Pseudomonas aeruginosa were related to a prolonged respiratory weaning. This article is protected by copyright. All rights reserved.

Keywords: Bronchoalveolar Lavage; Coronavirus Disease 2019; Invasive Ventilation; Respiratory Co-infections; Severe Acute Respiratory Syndrome Coronavirus 2.
 
Back
Top Bottom